2invest AG (DB: 2INV)
Health Care · Biotechnology · DE
€7.96
+0.25% today · -37.8% 1Y
2invest AG (DB: 2INV) operates in the Biotechnology industry within the Health Care sector. The company is valued at $49.24M.
Over the last twelve months the share price has lost 37.8%, trading between 6.56 and 13.20.
Tweenvest scores 2invest AG across four factors: quality 55/100, value 33/100, growth 100/100. Its strongest factor is growth.
2INV price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $49.24M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -1.60
- Dividend yield
- —
- Beta (5Y)
- -0.03
- 52-week high
- €13.20
- 52-week low
- €6.56
- Avg volume (3M)
- —
- Shares outstanding
- 5.50M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Annovis Bio, Inc.NYSE: ANVS | $50.28M | $1.17 | -0.85% |
| CapForce Inc.OTCPK: CFOR | $50.21M | $4.05 | +0.25% |
| Serina Therapeutics, Inc.NYSEAM: SER | $49.78M | $2.01 | +2.55% |
| Dogwood Therapeutics, Inc.NasdaqCM: DWTX | $49.63M | $1.41 | -3.42% |
| Optipharm.CO.,LTDKOSDAQ: A153710 | $49.02M | ₩4,500.00 | -1.64% |
| Cutia TherapeuticsSEHK: 2487 | $48.98M | HK$1.03 | +8.99% |
| Transcenta Holding LimitedSEHK: 6628 | $48.97M | HK$0.90 | -13.88% |
| Instil Bio, Inc.NasdaqCM: TIL | $48.97M | $6.56 | -9.14% |
Figures last refreshed Oct 4, 2026.